ESP Block VS Intrathecal Opioid After Laparoscopic Colorectal Surgery
A
Amy McCutchan, MD
Primary Investigator
Overview
This study is being done to compare 2 types of pain control methods and determine which isve postoperatively for laparoscopic colorectal surgery. Group 1 will receive anhecal (IT) injection in the back in which a small dose duramorph and bupivacaine will
be placed into the spinal fluid. Group 2 will receive an erector spinae plane (ESP) block in
which bupivacaine and decadron are injected near the nerves under a muscle in the back.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Surgery
-
Age: Between 18 Years - 80 Years
-
Gender: All
Inclusion Criteria:
- Patients undergoing an elective laparoscopic colorectal procedure at Indianaversity Hospital or Methodist Hospital
- ASA Class 1, 2, 3 (American Society of Anesthesiologists physical statusystem)
- Age 18 to 80 years (male or female)
- BMI < 40kg/m2
- Desires regional anesthesia for postoperative pain control
Exclusion Criteria:
- Any contraindication for neuraxial analgesia or ESP block procedure
- Contraindications for neuraxial analgesia include: Elevated intracranial pressure(except in cases of pseudo-tumor cerebri), infection at the site of injection,k of consent from the patient, patient refusal, true allergy to any drug usedhe spine, and uncorrected hypovolemia.
- Contraindications for ESP block procedure include: Infection at the site ofjection, patient refusal, true allergy to any of the drugs used in the block,d lack of patient consent.
- Any patient undergoing a laparoscopic abdominoperineal resection.
- Any physical, mental or medical conditions which, in the opinion of the investigators,y confound quantifying postoperative pain resulting from surgery.
- Known true allergy to the study medications (morphine, bupivacaine, decadron, Tylenol,Celebrex)
- Takes over 30 mg of oral morphine equivalents daily
- Any history of substance abuse in the past 6 months
- End stage liver disease, end stage renal disease
- Body weight of < 50 kg
Updated on
02 May 2024.
Study ID: 12514
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
